In conditions of cancer (Fig. 1B), different types of tumour cells and the tumour microenvironment generate large amounts of TGF-β which differ not only among tumour types but can also vary significantly among patients suffering from the same cancer type. This evidence concerns the gene TGFB1 and neoplasm.